Topical corticosteroids work non-specifically to reduce inflammation in the skin by preventing cells from producing inflammation-causing chemicals that are released in response to a variety of different triggers.
Vtama works in a more targeted manner to activate the aryl hydrocarbon receptor (AHR) to downregulate inflammatory pathways and improve barrier function. Because Vtama is not a topical corticosteroid, it is able to be used over a longer period of time,2,3 and on body areas that are more delicate or have thinner skin, such as the face, genitals, or skin folds, where topical corticosteroid use is not preferred.